Share on StockTwits

Ironwood Pharmaceuticals (NASDAQ:IRWD) will release its earnings data on Tuesday, April 29th. Investors interested in participating in the company’s conference call can do so using this link.

Shares of Ironwood Pharmaceuticals (NASDAQ:IRWD) opened at 10.68 on Monday. Ironwood Pharmaceuticals has a 52-week low of $8.95 and a 52-week high of $16.00. The stock’s 50-day moving average is $11.99 and its 200-day moving average is $11.9. The company’s market cap is $1.297 billion.

A number of analysts have recently weighed in on IRWD shares. Analysts at Bank of America upgraded shares of Ironwood Pharmaceuticals to a “buy” rating in a research note on Wednesday, April 23rd. On the ratings front, analysts at Zacks downgraded shares of Ironwood Pharmaceuticals from an “outperform” rating to a “neutral” rating in a research note on Friday, April 11th. They now have a $11.00 price target on the stock. Finally, analysts at Aegis reiterated a “buy” rating on shares of Ironwood Pharmaceuticals in a research note on Tuesday, March 18th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $11.54.

Ironwood Pharmaceuticals, Inc is a pharmaceutical company, which discovers, develops and intends to commercialize differentiated medicines.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.